TY - JOUR
T1 - Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50-year-old women
AU - Schmitz, Kathryn H.
AU - Ahmed, Rehana L.
AU - Yee, Douglas
PY - 2002/12/1
Y1 - 2002/12/1
N2 - We assessed the effects of twice weekly strength training on several proposed risk factors for breast and colon cancer: body fat, waist circumference, fasting insulin, fasting glucose, insulin-like growth factor I (IGF-I), and several IGF-binding proteins. Fifty-four healthy women, 30-50 years old, were randomized to no-contact control or treatment: 15 weeks of supervised strength training followed by 6 months of unsupervised training. Fifteen-week changes included reductions in percentage of body fat, fasting insulin, fasting glucose, and IGF-I that were larger in the treatment than control participants (treatment versus control mean ± SE: % body fat -1.97 ± 0.42 versus -0.43 ± 0.40, P = 0.01; insulin (uU/ml) -0.29 ± 0.35 versus 0.81 ± 0.38, P = 0.055; glucose (mg/dl) -1.92 ± 1.27 versus 1.21 ± 1.36, P = 0.13; and IGF-I (ng/ml) -30.47 ± 9.75 versus 5.86 ± 10.44, P = 0.02). There was no treatment effect on IGF-binding proteins 1 and 3 or either of two surrogate measures of free IGF-I. By 39 weeks changes in percentages of body fat were largely maintained; IGF-I returned to baseline levels in the treatment group but remained 15% lower in treatment compared with control participants. Strength training produced favorable changes in several proposed cancer risk factors. The importance of these changes to long-term cancer prognosis, diagnosis, and/or recurrence remains to be determined.
AB - We assessed the effects of twice weekly strength training on several proposed risk factors for breast and colon cancer: body fat, waist circumference, fasting insulin, fasting glucose, insulin-like growth factor I (IGF-I), and several IGF-binding proteins. Fifty-four healthy women, 30-50 years old, were randomized to no-contact control or treatment: 15 weeks of supervised strength training followed by 6 months of unsupervised training. Fifteen-week changes included reductions in percentage of body fat, fasting insulin, fasting glucose, and IGF-I that were larger in the treatment than control participants (treatment versus control mean ± SE: % body fat -1.97 ± 0.42 versus -0.43 ± 0.40, P = 0.01; insulin (uU/ml) -0.29 ± 0.35 versus 0.81 ± 0.38, P = 0.055; glucose (mg/dl) -1.92 ± 1.27 versus 1.21 ± 1.36, P = 0.13; and IGF-I (ng/ml) -30.47 ± 9.75 versus 5.86 ± 10.44, P = 0.02). There was no treatment effect on IGF-binding proteins 1 and 3 or either of two surrogate measures of free IGF-I. By 39 weeks changes in percentages of body fat were largely maintained; IGF-I returned to baseline levels in the treatment group but remained 15% lower in treatment compared with control participants. Strength training produced favorable changes in several proposed cancer risk factors. The importance of these changes to long-term cancer prognosis, diagnosis, and/or recurrence remains to be determined.
UR - http://www.scopus.com/inward/record.url?scp=0036907556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036907556&partnerID=8YFLogxK
M3 - Article
C2 - 12496050
AN - SCOPUS:0036907556
SN - 1055-9965
VL - 11
SP - 1597
EP - 1604
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 12
ER -